YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, an… Read more
Market Cap & Net Worth: YungShin Global Holding Corp (3705)
YungShin Global Holding Corp (TW:3705) has a market capitalization of $425.88 Million (NT$14.09 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #12996 globally and #404 in its home market, demonstrating a -2.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YungShin Global Holding Corp's stock price NT$52.90 by its total outstanding shares 266365000 (266.37 Million).
YungShin Global Holding Corp Market Cap History: 2015 to 2026
YungShin Global Holding Corp's market capitalization history from 2015 to 2026. Data shows growth from $249.02 Million to $425.88 Million (5.54% CAGR).
YungShin Global Holding Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YungShin Global Holding Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
YungShin Global Holding Corp's market cap is 0.05 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.37x
YungShin Global Holding Corp's market cap is 0.37 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $249.02 Million | $6.03 Billion | $893.25 Million | 0.04x | 0.28x |
| 2016 | $248.33 Million | $6.19 Billion | $657.99 Million | 0.04x | 0.38x |
| 2017 | $224.89 Million | $6.62 Billion | $514.06 Million | 0.03x | 0.44x |
| 2018 | $232.00 Million | $7.51 Billion | $701.98 Million | 0.03x | 0.33x |
| 2019 | $265.85 Million | $8.19 Billion | $748.60 Million | 0.03x | 0.36x |
| 2020 | $289.93 Million | $8.08 Billion | $791.72 Million | 0.04x | 0.37x |
| 2021 | $291.77 Million | $7.81 Billion | $736.62 Million | 0.04x | 0.40x |
| 2022 | $370.33 Million | $7.31 Billion | $839.03 Million | 0.05x | 0.44x |
| 2023 | $374.35 Million | $7.03 Billion | $827.30 Million | 0.05x | 0.45x |
| 2024 | $433.93 Million | $8.03 Billion | $1.17 Billion | 0.05x | 0.37x |
Competitor Companies of 3705 by Market Capitalization
Companies near YungShin Global Holding Corp in the global market cap rankings as of March 18, 2026.
Key companies related to YungShin Global Holding Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
YungShin Global Holding Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, YungShin Global Holding Corp's market cap moved from $249.02 Million to $ 425.88 Million, with a yearly change of 5.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$425.88 Million | -7.19% |
| 2025 | NT$458.89 Million | +5.75% |
| 2024 | NT$433.93 Million | +15.91% |
| 2023 | NT$374.35 Million | +1.09% |
| 2022 | NT$370.33 Million | +26.92% |
| 2021 | NT$291.77 Million | +0.63% |
| 2020 | NT$289.93 Million | +9.06% |
| 2019 | NT$265.85 Million | +14.59% |
| 2018 | NT$232.00 Million | +3.16% |
| 2017 | NT$224.89 Million | -9.44% |
| 2016 | NT$248.33 Million | -0.27% |
| 2015 | NT$249.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of YungShin Global Holding Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $425.88 Million USD |
| MoneyControl | $425.88 Million USD |
| MarketWatch | $425.88 Million USD |
| marketcap.company | $425.88 Million USD |
| Reuters | $425.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.